Designing and conducting a phase III clinical trial is very difficult.
The authors conducted a Phase I trial of escalating doses of CP using probenecid as a chemoprotector.
We conducted a phase II study of belinostat in patients with relapsed malignant pleural mesothelioma.
We conducted a phase II study of bortezomib in patients with advanced-stage BAC.
This prompted the drug firm GlaxoSmithKline in London, developers of the antibody, to conduct a phase II trial of its effect in ALS (see go.nature.com/2xkqclw).com/2xkqclw
As of March 2007 the University of Iowa is conducting a Phase I trial on a selective serotonin reuptake inhibitor (SSRI) called citalopram.
This combination was evaluated clinically.METHODS: We conducted a phase 1b study involving patients with relapsed or refractory non-Hodgkin's lymphoma.
We conducted a phase I-II study of transplantation conditioning with clofarabine-melphalan-alemtuzumab for patients with advanced hematologic malignancies.
Based on these findings, we conducted a phase 1 study of AzaC post DLI for AML relapse post allo-SCT.
By conducting a phase plane analysis and through some calculations, we obtain the analytical solutions of the equilibrium equation.
